Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective
AIDSPublished 1 August 1999
Jensa C. Bell, David N. Rose, Henry S. Sacks
Citations66
SJR quartileQ1
SJR score1.21
SNIP0.90
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
TB preventive therapy taken by HIV-infected tuberculin reactors in sub-Saharan Africa results in extended life-expectancy, reduction of the incidence of TB and monetary savings in medical care and social costs.
Abstract
TB preventive therapy taken by HIV-infected tuberculin reactors in sub-Saharan Africa results in extended life-expectancy, reduction of the incidence of TB and monetary savings in medical care and social costs. TB control policy in sub-Saharan Africa should include preventive therapy.
Keywords
Medicine
New England Journal of MedicineDeclining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
9,465 Citations1998Frank J. Palella, Kathleen M. Delaney +6 more
The recent declines in morbidity and mortality due to AIDS are attributable to the use of more intensive antiretroviral therapies.
New England Journal of MedicineA Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection
1,579 Citations1989Peter A. Selwyn, Diana Hartel +6 more
The data suggest that in HIV-infected persons tuberculosis most often results from the reactivation of latent tuberculous infection; these results lend support to recommendations for the aggressive use of chemoprophylaxis against tuberculosis in patients with HIV infection and a positive PPD test.
New England Journal of MedicineAn Outbreak of Tuberculosis with Accelerated Progression among Persons Infected with the Human Immunodeficiency Virus
996 Citations1992Charles L. Daley, Peter M. Small +5 more
There should be heightened surveillance for tuberculosis in facilities where HIV-infected persons live, and investigation of contacts must be undertaken promptly and be focused more broadly than is usual.
Medical Decision MakingThe Markov Process in Medical Prognosis
973 Citations1983J. Robert Beck, Stephen G. Pauker
A general- purpose model of medical prognosis based on the Markov process is described and it is shown how this simple mathematical tool may be used to generate detailed and accurate assessments of life expectancy and health status.
New England Journal of MedicineAn Outbreak of Multidrug-Resistant Tuberculosis among Hospitalized Patients with the Acquired Immunodeficiency Syndrome
881 Citations1992Brian R. Edlin, Jerome I. Tokars +10 more
Multidrug-resistant tuberculosis is readily transmitted among hospitalized patients with AIDS and Physicians must be alert to this danger and must enforce adherence to the measures recommended to prevent nosocomial transmission of tuberculosis.
AIDSThe mortality and pathology of HIV infection in a West African city
564 Citations1993Sebastian Lucas, A. Hounnou +16 more
In this population, HIV-positive adults present to hospital with advanced disease associated with high mortality, and the three major underlying pathologies (TB, toxoplasmosis and bacteraemia) are either preventable or treatable.
American Journal of Respiratory and Critical Care MedicineAccelerated Course of Human Immunodeficiency Virus Infection after Tuberculosis
535 Citations1995Christopher Whalen, C. Robert Horsburgh +4 more
Although active tuberculosis may be an independent marker of advanced immunosuppression in HIV-infected patients, it may also act as a cofactor to accelerate the clinical course of HIV infection.
The LancetEffect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection
438 Citations1993Jean W. Pape, SIMONE S. JEAN +3 more
Isoniazid prophylaxis should be considered for HIV-seropositive, P PD-positive subjects, and may also be appropriate for PPD-negative patients in areas where tuberculosis is highly endemic.
New England Journal of MedicineA Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus
391 Citations1997Christopher C. Whalen, John L. Johnson +13 more
A six-month course of isoniazid confers short-term protection against tuberculosis among PPD-positive, HIV-infected adults and multidrug regimens with isoniaZid and rifampin taken for three months also reduce the risk of tuberculosis.
JAMAHigh Risk of Active Tuberculosis in HIV-Infected Drug Users With Cutaneous Anergy
288 Citations1992Peter A. Selwyn
The results support the routine use of delayed-type hypersensitivity testing for drug injectors with known or suspected HIV infection, and consideration of isoniazid prophylaxis for anergic as well as tuberculin-reactive subjects who are HIV seropositive, in populations with a high prevalence of coexisting HIV and Mycobacterium tuberculosis infection.
The LancetRandomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection
273 Citations1998Neal A. Halsey, Jacqueline Coberly +12 more
Journal of Acquired Immune Deficiency Syndromes & Human RetrovirologyUpdates of Cost of Illness and Quality of Life Estimates for Use in Economic Evaluations of HIV Prevention Programs
233 Citations1997David R. Holtgräve, Steven D. Pinkerton
The net effect of increases in the medical costs of care and treatment saved by averting an HIV infection and in QALYs makes HIV prevention a relatively more cost-effective strategy than other, non-HIV health-related programs.
JAMARisk Factors for Tuberculosis in HIV-lnfected Persons
220 Citations1995Giorgio Antonucci
Risk of tuberculosis in HIV-infected persons can be more precisely quantified by jointly considering skin test reactivity and CD4+lymphocyte count and periodic skin tests in tuberculin-negative nonanergic individuals can be useful in identifying individuals at high risk of active tuberculosis.
American Review of Respiratory DiseaseIsoniazid-associated Hepatitis Deaths: A Review of Available Information
206 Citations1992Dixie E. Snider, Gus J. Caras
The number of persons whose deaths may have been attributable to INH -associated hepatitis and the characteristics of these persons was obtained.
AIDSA prospective study of the risk of tuberculosis among HIV-infected patients
177 Citations1993Ana Guelar, José M. Gatell +9 more
Among HIV-infected patients in whom the tuberculin skin test is negative, the risk of developing active TB is sufficient to consider prophylaxis if the CD4 count falls below 400 $$ 106/l, at least in those patients with skin anergy living in high-risk geographical areas such as Spain.
Annals of Internal MedicineRisk for Developing Tuberculosis among Anergic Patients Infected with HIV
174 Citations1993Santiago Moreno, Josu Baraia-Etxaburu +8 more
The risk for developing tuberculosis among anergic and nonanergic HIV-infected persons and the convenience of broadening the indications of chemoprophylaxis to anergic patients in this area was assessed.
JAMARisk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA)
148 Citations1995G. Antonucci
Risk of tuberculosis in HIV-infected persons can be more precisely quantified by jointly considering skin test reactivity and CD4+ lymphocytes in the three groups of subjects with different skin test responsiveness.
AIDSIsoniazid preventive therapy for tuberculosis in HIV-1-infected adults
139 Citations1997Mark Hawken, Hellen Meme +15 more
Overall there was no statistically significant protective effect of daily isoniazid for 6 months in the prevention of tuberculosis, and in the TST‐positive subjects, there was some protection and some reduction in mortality, although this was not statistically significant.
AIDSHIV-1 incidence and HIV-1 -associated mortality in a rural Ugandan population cohort
133 Citations1994Daan Mulder, Andrew Nunn +3 more
These results demonstrate the profound impact that the HIV-1 epidemic has on adult mortality in a rural area of Uganda where theAIDS prevalence and incidence rates in adults are 8 and 1%, respectively.
BMJEffect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials
132 Citations1998David Wilkinson, S. Bertel Squire +1 more
Pre preventive treatment given for 3-12 months protects against tuberculosis in adults infected with HIV, at least in the short to medium term, and is greatest in subjects positive for purified protein derivative, in whom death is also less frequent.
BMJMortality associated with HIV-1 infection over five years in a rural Ugandan population: cohort study
124 Citations1997Andrew Nunn, Daan Mulder +4 more
To assess the impact of HIV-1 infection on mortality over five years in a rural Ugandan population, a cohort study followed up annually by a house to house census and medical survey is conducted.
American Review of Respiratory DiseaseA Retrospective Cohort Study of the Risk of Tuberculosis Among Women of Childbearing Age with HIV Infection in Zaire
109 Citations1991Michelle Braun, Nsanga Badi +8 more
It is estimated that 66 cases of proven pulmonary tuberculosis in 100,000 person-years of follow-up in women of childbearing age could be attributed to HIV; this is 35% of their estimated total incidence ofproven pulmonary tuberculosis.
PubMedFatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.
85 Citations1993Shelley R. Salpeter
The rate of fatal isoniazid-induced hepatitis during chemoprophylaxis that is done according to current monitoring guidelines is significantly lower than was previously estimated and should be used to reevaluate the benefit of preventive therapy for tuberculin-reactive patients older than 35.
JAMAHigh risk of active tuberculosis in HIV-infected drug users with cutaneous anergy
81 Citations1992Peter A. Selwyn
The LancetPreventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice
68 Citations1995Kevin M. De Cock, Alison D. Grant +1 more
The authors briefly discuss preventive therapy for TB in HIV-infected persons, research issues, and the international role of preventive therapy.
Social Science & MedicineAn economic evaluation of alternative programme designs for tuberculosis control in rural Uganda
67 Citations1995Paul Saunderson
It is concluded that a programme based on the ambulatory treatment of patients at their nearest health unit, whilst living at home, is the most cost-effective design, largely because of reduced costs to the patients themselves.
American Journal of EpidemiologyProgression of Human Immunodeficiency Virus Infection in Patients with Tuberculosis Disease: A Cohort Study in Bordeaux, France, 1988-1994
55 Citations1997Valériane Leroy, Louis‐Rachid Salmi +7 more
Tuberculosis disease affected survival but not occurrence of subsequent opportunistic infections or rate of CD4+ count decline, suggesting that tuberculosis may be a marker of advanced HIV and may accelerate its course of infection.
AIDSPreventive therapy for tuberculosis in HIV infection
38 Citations1995Richard O’Brien, Joseph H. Perriëns
Recommendation is the approach adopted in the US of providing a six-month course of isoniazid to those with a positive tuberculin skin test reaction and epidemiologic risk factors; for those already infected with HIV, 12 months of treatment is suggested.
AIDSModelling the economic benefits of tuberculosis preventive therapy for people with HIV
30 Citations1997Susan D. Foster, Peter Godfrey‐Faussett +1 more
Assessment of the economic benefits and costs of providing isoniazid preventive therapy for tuberculosis (TB) in HIV‐infected persons in Zambia indicates that the targeted preventive therapy of persons with HIV whose occupation or living situation places them in contact with a large number of others would yield significant net benefits.
PubMedIsoniazid prophylactic therapy for tuberculosis in HIV-seropositive patients--a least-cost analysis.
18 Citations1995Patrick Masobe, Thomas Yi Teh Lee +1 more
A computer spreadsheet model was developed to estimate the costs and benefits that would result from isoniazid chemoprophylaxis for tuberculosis in a hypothetical cohort of 100,000 HIV-seropositive people in South Africa over a period of 8 years.
PubMedResource utilization patterns in patients with acquired immunodeficiency syndrome (AIDS).
5 Citations1994D O Okello
A study was conducted in Kampala Uganda to assess drug utilization by AIDS patients and ketoconazole cotrimoxazole and metronidazole used for the treatment of oral candida and gastrointestinal symptoms were associated with the highest mean cost per treatment episode.